GENE ONLINE|News &
Opinion
Blog

TNBC
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Checkpoint Inhibitors as Part of Neoadjuvant Therapy in TNBC: Should We Use Them or Not?
2021-10-03
R&D
Recent Advances in Triple Negative Breast Cancer Treatments
2021-04-26
Roche’s Multifaceted Drug, Tecentriq Registers Mixed Results in Breast Cancer Patients
2020-09-22
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
Trodelvy Gives New Hope to Patients with Relapsing Breast Cancer
2020-07-09
R&D
ASCO 2020: Keytruda Chemo Combo Show Significant Benefit in PD-L1 Expressing mTNBC
2020-06-03
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top